Randomized Trial: Long-term Survival following Multivessel Revascularization in Patients with Diabetes
16 Nov, 2018 | 02:50h | UTCLong-term Survival following Multivessel Revascularization in Patients with Diabetes (FREEDOM Follow-On Study) – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentaries: Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI – TCTMD (free) AND FREEDOM Follow-On Study Findings Further Support CABG Over PCI in DM Patients With CAD – American College of Cardiology (free) AND AHA: CABG Still Better for Multivessel Disease in Diabetes – MedPage Today (free registration required)